Kardiyovasküler risk ve diyabeti belirlemede şişmanlık nasıl ölçülmeli?

Yüksek kan basıncı, yüksek kan yağları ve bozulmuş glukoz toleransı diyabet ve kardiyovasküler hastalıklar gibi hastalıklar için risk etmenidir. Sigara kullanımı, kötü beslenme ve hareketsiz yaşam bu risk etmenlerinin oluşumunu artırmaktadır. Şişmanlık bedendeki yağ miktarının istenen düzeyden fazla olmasıdır. Beden kütle indeksi (BKI), bel çevresi (BÇ), bel kalça oranı (BKO) şişmanlığın değerlendirilmesinde en sık kullanılan antropometrik ölçümlerdir. Bu derlemenin amacı kardiyovasküler hastalıklardan ölümlerin, kardiyovasküler olayların ve diyabetin öngörülmesinde hangi antropometrik yöntemin yeğlenmesi gerektiği konusunda bilgi sunmaktır. Bu amaçla geniş katılımlı toplum tabanlı çalışmalar incelenmiş, bulguları tartışılmıştır. Yapılan çalışmalara dayanarak, yeterli araç gereç varsa kardiyovasküler riskin ortaya konmasında hem BKI, hem de abdominal şişmanlık ölçütlerinden birisinin (bel çevresi ya da bel kalça oranı) birlikte kullanılması önerilebilir.

How to determine obesity to estimate cardiovascular risk and diabetes?

High blood pressure, high serum lipids and impaired glucose tolerance are risk factors of cardiovascular diseases and diabetes. Smoking, malnutrition and sedentary life increase the occurrence of these risk factors. Obesity is defined as accumulation of fat more than the desired level. Body mass index (BKI), waist circumference (WC) and waist hip ratio (WHR) are the anthropometric measurements that are widely used for defining obesity. The aim of this paper is to present evidence on which anthropometric measurement must be chosen to estimate deaths from cardiovascular diseases, cardiovascular events and diabetes. For this purpose large population based studies were evaluated and their findings were discussed. According to the results of these studies it is recommended that if there is enough time and equipment, BMI and one of the abdominal measurements (WC or WHR) should be evaluated together for a better estimation.

PDF

___

1- Meseri R, Unal B. Hastalık Kontrol Programları. STED. 2008; 17(4): 57-61.
2- WHO. World Health Organization. Cardiovascular diseases; What are cardiovascular diseases? www_who_int/mediacentre/factsheets/fs317/en/in dex html, [Erişim Tarihi: 22/06/2009].
3- Pekcan G, Alphan E, Köksal E, Küçükerdönmez Ö, Bayrak M, Kızıltan G, et al. Yetişkinlerde ağırlık yönetimi. İstanbul: Türkiye Diyetisyenler Derneği Yayını; 2008.
4- National health and medical research council. Clinical Practice Guidelines for the Management of Overweight and Obesity in Adults.
5- Sun G, French CR, Martin GR, Younghusband B, Green RC, Xie YG, et al. Comparison of multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for assessment of percentage body fat in a large, healthy population. Am. J. Clin. Nutr. 2005 Jan; 81(1): 74-8.
6- Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am. J. Clin. Nutr. 2005 Mar; 81(3): 555-63.
7- Roubenoff R. Applications of bioelectrical impedance analysis for body composition to epidemiologic studies. Am. J. Clin. Nutr. 1996 Sep; 64(3 Suppl): 459S-62S.
8- Kotler DP, Burastero S, Wang J, Pierson RN, Jr. Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease. Am. J. Clin. Nutr. 1996 Sep; 64(3 Suppl): 489S-97S.
9- Bolanowski M, Nilsson BE. Assessment of human body composition using dual-energy x-ray absorptiometry and bioelectrical impedance analysis. Med. Sci. Monit. 2001; Sep;7(5): 1029-33.
10- Despres JP. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. European Heart Journal Supplements. 2006; 8(Supplement B): B4-B12.
11- Balkau B, Deanfield JE, Despres JP, Bassand JP, Fox KA, Smith SC, Jr., et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation. 2007; 116(17): 1942-51.
12- Ardern CI, Katzmarzyk PT, Janssen I, Ross R. Discrimination of health risk by combined body mass index and waist circumference. Obes. Res. 2003; 1(1): 135-42.
13- Ross R, Berentzen T, Bradshaw AJ, Janssen I, Kahn HS, Katzmarzyk PT, et al. Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference? Obes. Rev. 2007; 9(4): 312-25.
14- The Endocrine Society. Research Demonstrates Waist-to-Tallness Ratio Is Simple, Effective Indicator of Obesity and Cardiovascular Risk (4 June 2005). www endo-society org [Erişim Tarihi: 22/06/2009].
15- Welborn TA, Dhaliwal SS. Preferred clinical measures of central obesity for predicting mortality. Eur. J. Clin. Nutr. 2007; 61(12): 1373-9.
16- Chen L, Peeters A, Magliano DJ, Shaw JE, Welborn TA, Wolfe R, et al. Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Eur. J. Cardiovasc. Prev. Rehabil. 2007; 14(6): 740-5.
17- Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998; 280(21): 1843-8.
18- Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27,000
participants from 52 countries: a case-control study. Lancet. 2005; 366(9497): 1640-9.
19- Canoy D, Boekholdt SM, Wareham N, Luben R, Welch A, Bingham S, et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation. 2007; 116(25): 2933-43.
20- Vazquez G, Duval S, Jacobs DR, Jr., Silventoinen K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol. Rev. 2007; 29: 115-28.
21- Balkau B, Sapinho D, Petrella A, Mhamdi L, Cailleau M, Arondel D, et al. Prescreening tools for diabetes and obesity-associated dyslipidaemia: comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study. Eur. J. Clin. Nutr. 2006; 60(3): 295-304.
22- Hu D, Xie J, Fu P, Zhou J, Yu D, Whelton PK, et al. Central rather than overall obesity is related to diabetes in the Chinese population: the InterASIA study. Obesity (Silver Spring). 2007; 15(11): 2809-16.
23- Stevens J, Couper D, Pankow J, Folsom AR, Duncan BB, Nieto FJ, et al. Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obes. Res. 2001; 9(11): 696-705.